Identification of classifier genes for hepatotoxicity prediction in non steroidal anti inflammatory drugs

Molecular and Cellular Toxicology

Volumn 6, Issue 3, 2010, Pages 247-253

  Cha, Hye Jin ^a   Ko, Moon Jung ^b   Ahn, Soo Mi ^a   Ahn, Joon Ik ^a   Shin, Hee Jung ^a   Jeong, Ho Sang ^a   Kim, Hye Soo ^b   Choi, Sun Ok ^a   Kim, Eun Jung ^a  

^a National Institute of Food and Drug Safety Evaluation   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Classifier identification; Hepatotoxicity; HepG2 cell; NSAID; Specificity; Toxicogenomics

Indexed keywords

EID: 79951892019     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-010-0034-1     Document Type: Article

References (29)

1. Walker, A. M. Quantitative studies of the risk of serious hepatic injury in person using nonsteroidal antiinflammatory drugs. Arthritis Rheum 40:201-208 (1997). (Pubitemid 27114083)
2. Chang, C. Y. & Schiano, T. D. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 25:1135-1151 (2007). (Pubitemid 46650295)
3. Bjorkman, D. Nonsteroidal anti-inflammatory drugassociated toxicity of the liver, lower gastrointestinal tract, and esophagus. Am J Med 105:17S-21S (1998). (Pubitemid 28553711)
4. O'Connor, N., Dargan, P. I. & Jones, A. L. Hepatocellular damage from non-steroidal anti-inflammatory drugs. Q J Med 96:787-791 (2003). (Pubitemid 37369293)
5. US FDA Guidance for Industry. Drug-induced liver injury: premarketing clinical evaluation (2009).
6. US FDA Report: Critical Path Opportunities (2004).
7. Dambach, D. M. et al. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093-1103 (2002). (Pubitemid 34454006)
8. Heidrun, E. Z. et al. Prediction of a carcinogenic potential of rat hepatocariconogens using toxicogenomics analysis of short-term in vivo studies. Mutat Res 637:23-39 (2008).
9. Goodsaid, F. & Frueh, F. Biomarker qualification pilot process at the US Food and Drug Administration. AAPS J 9: E105-E108 (2007).
10. Harries, H. M. et al. The use of genomics technology. Toxicol In Vitro 15:399-405 (2001).
11. Aithal, G. P. & Day, C. P. Nonsteroidal anti-inflammatory drug-induced hepato-toxicity. Clin Liver Dis 11:563-575 (2007).
12. Chitturi, S. & George, J. Hepatotoxicity of commonly used drugs: Nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 22:169-183 (2002). (Pubitemid 34496470)
13. Clark, R. D. et al. Modelling in vitro hepatotoxicity using molecular interaction fields and SIMCA. J Mol Graph Model 22:487-497 (2004). (Pubitemid 38746574)
14. Ogata, H. et al. KEGG: Kyoto Encyclopedia of genes and genomes. Oxford University Press 27:29-34 (1999). (Pubitemid 29209394)
15. Flynn, J. F. & Ferguson, M. S. Multiendpoint mechanistic profiling of hepatotoxicants in HepG2/C3A human hepatoma cells and novel statistical approaches for development of a prediction model for acute hepatotoxicity. Toxicol In Vitro 22:1618-1631 (2008).
16. Waring, J. F. et al. Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences. Toxicogenomics 111:863-870 (2003). (Pubitemid 36701366)
17. Maggioli, J., Hoover, A. & Weng, L. Toxicogenomic analysis methods for predictive toxicology. J Pharm Toxicol Methods 53:31-37 (2006). (Pubitemid 43052701)
18. Kulkarni, K., Larsen, P. & Linninger, A. A. Assessing chronic liver toxicity based on relative gene expression data. J Theor Biol 254:308-318 (2008).
19. Thomas, P. D. et al. Panther: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 31:334-341 (2003). (Pubitemid 36150398)
20. Thum, T. & Borlak, J. Detection of early signals of hepatotoxicity by gene expression profiling studies with cultures of metabolically competent human hepatocytes. Arch Toxicol 82:89-101 (2008). (Pubitemid 351187672)
21. Liguori, M. J., Blomme, E. A. G. & Waring, J. F. Trovafloxacin- induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells. Drug Metab Dispos 36:223-233 (2008). (Pubitemid 351185733)
22. Elferink, M. G. L. et al. Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. Toxicol Appl Pharmacol 229:300-309 (2008).
23. Otto, M. et al. Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity. Cell Biol Toxicol 24:87-99 (2008).
24. Liguori, M. J. et al. Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology 41:177-186 (2005). (Pubitemid 40066396)
25. Dai, X. et al. Development of an approach for Ab Initio estimation of compound-induced liver injury based on global gene transcriptional profiles. Genome Inform 17:77-88 (2006).
26. Uehara, T. et al. Gene expression profiling of methapyrilene-induced hepatotoxicity in rat. J Toxicol Sci 33:37-50 (2008). (Pubitemid 351340762)
27. Burczynski, M. E. et al. Toxicogenomics-Based discrimination of toxic mechanism in HepG2 human hepatoma cells. J Toxicol Sci 58:399-415 (2000). (Pubitemid 32042437)
28. Zidek, N. et al. Acute hepatotoxicity: A predictive model based on focused illumina microarray. Toxicol Sci 99:289-302 (2007). (Pubitemid 47250386)
29. Kazunari, T. et al. Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells. Cancer Sci 97:1002-1010 (2006).